PACB Insider Trading Activity and SEC Form 4 Filings
PACB insider trading summary
Over the past 12 months, insiders at Pacific Biosciences of California, Inc. (PACB) reported 12 sales worth $3.4M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $3.4M.
Latest PACB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 6, 2026 | James R Gibson II | See Remarks | Sell | $2.1M (661,815 @ $3.11) |
| Aug 17, 2026 | Oene Mark Van | See Remarks | Sell | $30K (26,911 @ $1.13) |
| Apr 1, 2026 | James R Gibson II | See Remarks | Sell | $121K (88,185 @ $1.37) |
| Mar 3, 2026 | Michele Farmer | See Remarks | Sell | $5K (2,979 @ $1.51) |
| Mar 3, 2026 | Christian O Henry | See Remarks | Sell | $19K (12,497 @ $1.51) |
| Mar 3, 2026 | Oene Mark Van | See Remarks | Sell | $10K (6,504 @ $1.51) |
| Feb 18, 2026 | Michele Farmer | See Remarks | Sell | $24K (14,952 @ $1.63) |
| Feb 18, 2026 | Oene Mark Van | See Remarks | Sell | $90K (55,107 @ $1.63) |
| Feb 18, 2026 | Christian O Henry | See Remarks | Sell | $229K (140,874 @ $1.63) |
| Feb 17, 2026 | Christian O Henry | See Remarks | Sell | $523K (331,793 @ $1.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.